Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy

Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy

INTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy.

Saved in:

Bibliographic Details
Main Authors:	Lalit Saini, Jack T Seki, Deepali Kumar, Eshetu G Atenafu, David EC Cole, Betty YL Wong, Andrea Božović, Joseph M Brandwein
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:	http://dx.doi.org/10.1155/2014/214813
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Voriconazole-induced periostitis in the hand
by: Gurbinder Singh, et al.
Published: (2025-03-01)

Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults
by: Hao Li, et al.
Published: (2025-01-01)

Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis
by: Vaibhav Agrawal, et al.
Published: (2020-01-01)

Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults
by: Coleman Rotstein, et al.
Published: (2008-01-01)

Corneal Debridement Combined with Intrastromal Voriconazole for Recalcitrant Fungal Keratitis
by: Yajie Sun, et al.
Published: (2018-01-01)

Successful Treatment of Candida parapsilosis Fungemia in Two Preterms with Voriconazole
by: Emel Altuncu, et al.
Published: (2015-01-01)

Efficacy of Voriconazole Corneal Intrastromal Injection for the Treatment of Fungal Keratitis
by: Chenshuang Li, et al.
Published: (2021-01-01)

Fusarium Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole
by: Ahmed M. Alkhunaizi, et al.
Published: (2018-01-01)

Two Case Presentations Infected by Trichosporon asahii and Treated with Voriconazole Successfully
by: Hikmet Gulsah Tanyildiz, et al.
Published: (2015-01-01)

An Economic Evaluation of Voriconazole versus Amphotericin B for the Treatment of Invasive Aspergillosis in Canada
by: Coleman Rotstein, et al.
Published: (2004-01-01)

Refractory Scedosporium apiospermum Keratitis Successfully Treated with Combination of Amphotericin B and Voriconazole
by: Mohd-Tahir Fadzillah, et al.
Published: (2013-01-01)

Fungal Keratitis Caused by Drechslera spp. Treated with Voriconazole: A Case Report
by: Margarita I. Echavez, et al.
Published: (2013-01-01)

Multifocal Aggressive Squamous Cell Carcinomas Induced by Prolonged Voriconazole Therapy: A Case Report
by: C. Morice, et al.
Published: (2010-01-01)

Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
by: Karen Sweiss, et al.
Published: (2016-01-01)

Safety and recommendation of voriconazole for invasive pulmonary aspergillosis in severe liver disease patients: a retrospective cohort study
by: Xin Zhang, et al.
Published: (2025-01-01)

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
by: Santiago Grau, et al.
Published: (2015-10-01)

Voriconazole Pharmacokinetics Administered at 4 mg/kg IM and IV in Nursehound Sharks (<i>Scyliorhinus stellaris</i>) Under Human Care
by: Daniela Cañizares-Cooz, et al.
Published: (2025-01-01)

Oncolytic Virotherapy for Hematological Malignancies
by: Swarna Bais, et al.
Published: (2012-01-01)

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
by: Pradyumna Agasthi, et al.
Published: (2018-01-01)

Ulcerative Colitis in Hematological Malignancies: Paraneoplastic Manifestation or Coincidental Bystander?
by: Gregorios Christodoulidis, et al.
Published: (2020-01-01)

Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
by: William A. Fabricius, et al.
Published: (2016-01-01)

Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies
by: Junko Okabe-Kado, et al.
Published: (2012-01-01)

Frequency and Treatment Outcome of Invasive Fungal Infections in Children with Hematological Malignancies
by: Rabiha Manzoor, et al.
Published: (2025-01-01)

Immune-Mediated Neutropenia and Thrombocytopenia in a Patient with Ulcerative Colitis: An Unusual Hematological Association with IBD
by: Young-In Kim, et al.
Published: (1995-01-01)

ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives
by: Marco Folci, et al.
Published: (2019-01-01)

Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies
by: Bobbak Vahid, et al.
Published: (2008-01-01)

BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
by: Mariam Markouli, et al.
Published: (2025-01-01)

Clinical Characteristics and Optimization of Empirical Antimicrobial Therapy for Febrile Neutropenia in Patients With Hematologic Malignancies
by: Cui Y, et al.
Published: (2025-02-01)

Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies
by: Richard P. Phipps, et al.
Published: (2008-01-01)

Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
by: P. J. Simpson-Haidaris, et al.
Published: (2010-01-01)

Modified screening and management strategies for chronic rhinosinusitis in hematologic patients receiving hematopoietic stem cell transplantation
by: Yen-Hui Lee, et al.
Published: (2025-02-01)

Predictive value of serum procalcitonin level for the diagnosis of bloodstream infections in hematological patients
by: Qi Sun, et al.
Published: (2025-02-01)

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
by: Xiang-mei Wen, et al.
Published: (2025-02-01)

Newer Clinical Strategies for Combining Interferon and Cytotoxic Agents Against Solid Tumours and Hematological Malignancies
by: Scott Wadler
Published: (1994-01-01)

Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies
by: Ilaria Laurenzana, et al.
Published: (2018-01-01)

Virological Aspects of COVID-19 in Patients with Hematological Malignancies: Duration of Viral Shedding and Genetic Analysis
by: Asma Themlaoui, et al.
Published: (2024-12-01)

40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies
by: Kristen Corrao, et al.
Published: (2025-01-01)

Prevalence of platinum-induced ototoxicity among patients suffering from hematological malignancies – a systematic review
by: Aleksandra Janowiak-Majeranowska, et al.
Published: (2024-07-01)

Serum fibronectin levels in malignant and benign endometrial diseases
by: Dimitar Mitev, et al.
Published: (2024-10-01)

A New Challenging Strategy in the Prevention and Management of Tumor Lysis Syndrome in Patients with Chemo-Sensitive Hematological Malignancies
by: Ammar ELJack, et al.
Published: (2019-01-01)